Paul K. Paik
Memorial Sloan Kettering Cancer Center(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → OncoKB: A Precision Oncology Knowledge Base(2017)2,642 cited
- → Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations(2020)836 cited
- → Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations(2011)689 cited
- → Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies(2017)654 cited
- → Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS -Mutant Cancers(2012)609 cited
- → Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping(2015)569 cited
- → Prevalence, Clinicopathologic Associations, and Molecular Spectrum of ERBB2 ( HER2 ) Tyrosine Kinase Mutations in Lung Adenocarcinomas(2012)494 cited
- → Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets(2016)463 cited
- → Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors(2021)440 cited
- → IFN-γ Suppresses IL-10 Production and Synergizes with TLR2 by Regulating GSK3 and CREB/AP-1 Proteins(2006)405 cited